| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | INTUITIVE SURGICAL INC | 37,000 | 20,208,000 | 6.81% | ||
| 2 | EDWARDS LIFESCIENCES CORP | 252,500 | 19,942,000 | 6.72% | ||
| 3 | SHIRE PLC | 92,030 | 18,866,000 | 6.36% | ||
| 4 | BIOGEN INC | 58,161 | 17,818,000 | 6.01% | ||
| 5 | ENDO INTL | 255,080 | 15,616,000 | 5.26% | ||
| 6 | BAXALTA INC | 385,000 | 15,027,000 | 5.07% | ||
| 7 | CERNER CORP | 216,339 | 13,017,000 | 4.39% | ||
| 8 | NEVRO CORP | 190,000 | 12,827,000 | 4.32% | ||
| 9 | IMPAX LABORATORIES INC | 295,000 | 12,614,000 | 4.25% | ||
| 10 | HOLOGIC INC | 325,747 | 12,603,000 | 4.25% | ||
| 11 | QUEST DIAGNOSTICS INC | 175,160 | 12,461,000 | 4.20% | ||
| 12 | COOPER COS INC | 90,000 | 12,078,000 | 4.07% | ||
| 13 | AGILENT TECHNOLOGIES INC | 285,000 | 11,916,000 | 4.02% | ||
| 14 | NEUROCRINE BIOSCIE COM USD0.001 | 200,060 | 11,317,000 | 3.81% | ||
| 15 | BRISTOL MYERS SQUIBB CO | 164,518 | 11,317,000 | 3.81% | ||
| 16 | Wright Medical Group NV | 450,000 | 10,881,000 | 3.67% | ||
| 17 | CEPHEID | 290,000 | 10,594,000 | 3.57% | ||
| 18 | VERTEX PHARMACEUT | 80,020 | 10,069,000 | 3.39% | ||
| 19 | QIAGEN NV | 360,000 | 9,954,000 | 3.36% | ||
| 20 | DEPOMED INC | 535,000 | 9,700,000 | 3.27% | ||
| 21 | PERRIGO CO PLC | 65,600 | 9,492,000 | 3.20% | ||
| 22 | ST JUDE | 152,500 | 9,420,000 | 3.18% | ||
| 23 | MASIMO CORP COM | 215,000 | 8,925,000 | 3.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-081602, filed 2016.02.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
